Inhalational and topical steroids, and oral candidosis: a mini review.
about
The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalersChronic hyperplastic candidosis/candidiasis (candidal leukoplakia).Ciclesonide for the treatment of asthma.Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus speciesPrevalence of oral Candida carriage and Candida species among cigarette and maras powder users.Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicansTopical corticosteroids in dental practice.Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.Therapeutic doses of glucocorticoids: implications for oral medicine.Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide.Oral Candida carriage and prevalence of Candida species among Maras powder users and non-users.Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis.Changes in the cell surface hydrophobicity of oral Candida albicans from smokers, diabetics, asthmatics, and healthy individuals following limited exposure to chlorhexidine gluconate.Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia.Effects of fluticasone propionate dosage in an experimental model of feline asthma.Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus.Oral viscous budesonide as a first-line approach to esophageal stenosis in epidermolysis bullosa: an open-label trial in six children.Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.The postantifungal effect and phospholipase production of oral Candida albicans from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to subtherapeutic concentrations of chlorhexidine gluconate.Oral carriage of cariogenic bacteria and Candida albicans in asthmatic adults before and after anti-asthma medication: A longitudinal study.Amplitude-modulated cold atmospheric pressure plasma jet for treatment of oral candidiasis: In vivo study.
P2860
Q31079772-26C76737-D230-42EB-870D-550DA3DFB230Q34220896-D12FCCC7-766A-4741-B417-C8F1818C8475Q35166788-9D31410A-50CA-4A9E-AC2E-42CBDC6B1423Q35214605-B406D53E-8C04-4D0D-B10D-096D338C40A2Q35959499-0AD9A28C-49E8-4676-809E-3D6AB4627F8EQ36029162-113D59F0-B103-411A-BCD2-1382BCA13E20Q36370259-218CE3D2-6570-4211-8A5A-736ABC9F48CBQ36455870-C28F6306-49FB-4519-8375-D10AC595F6D6Q36566569-D37812B9-505B-4031-9459-7B8F803B1D60Q38541845-89EAEE3D-43B0-46FB-8E6C-AC7D42829E58Q39084186-E3E64FCE-E78C-4079-805B-249757496405Q41742285-51445A35-0DE9-41F8-B38C-D686C2E1045FQ41874538-52BD8F99-ABD9-4A61-8C96-89606C547961Q42759820-ED719ADF-E16F-4CD6-A180-58424855F09FQ43239609-CA09B3E0-BF08-4EF5-B7B3-CF5463FF5905Q43300894-79553CF8-4CAA-48FD-BBED-635171A34E6FQ43856150-7AC6C7FF-93C8-4BA0-B3CC-BBBAED234523Q48067767-56FA4E33-1060-4FE5-B976-E4C5FE350092Q49679946-7077A548-C580-4F84-8669-73D022F8D718Q53593156-EAF70318-664C-4598-8557-C8DAA78F9F1EQ55300591-0A6402A3-DF40-4703-95EB-22D7CF847B6AQ55455215-C55864F0-F250-4A49-8674-1641E141F520
P2860
Inhalational and topical steroids, and oral candidosis: a mini review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhalational and topical steroids, and oral candidosis: a mini review.
@ast
Inhalational and topical steroids, and oral candidosis: a mini review.
@en
Inhalational and topical steroids, and oral candidosis: a mini review.
@nl
type
label
Inhalational and topical steroids, and oral candidosis: a mini review.
@ast
Inhalational and topical steroids, and oral candidosis: a mini review.
@en
Inhalational and topical steroids, and oral candidosis: a mini review.
@nl
prefLabel
Inhalational and topical steroids, and oral candidosis: a mini review.
@ast
Inhalational and topical steroids, and oral candidosis: a mini review.
@en
Inhalational and topical steroids, and oral candidosis: a mini review.
@nl
P2860
P1433
P1476
Inhalational and topical steroids, and oral candidosis: a mini review.
@en
P2093
Ellepola AN
Samaranayake LP
P2860
P304
P356
10.1034/J.1601-0825.2001.70402.X
P577
2001-07-01T00:00:00Z